Plans have been submitted to build a £400 million science campus in Harlow.

The Public Health England (PHE) facility will be developed on the former GlaxoSmithKline site at the Pinnacles Industrial Estate.

If approved, PHE will co-locate most of its current facilities at Porton in Wiltshire, Colindale in north London and its central London headquarters, to a single centre of excellence for public health research, improvement and protection.


In addition, the project will create thousands of construction-related jobs during the site's development.

Richard Gleave, Deputy Chief Executive for PHE, said: "I am delighted that we have now submitted our plans for consideration, following extensive discussions with the local community, relevant authorities and other stakeholders.

"We want to make Harlow our home and we believe the science campus will bring long-term benefits for the area, as well as unique opportunities for public health research on a national and international scale."

Building work is expected to start in 2019, with phased occupation starting in 2021.

(LM)